EC Number | Application | Comment | Organism |
---|---|---|---|
1.1.1.25 | drug development | the enzyme is a promising target for antituberculosis agent development | Mycobacterium tuberculosis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.1.1.25 | A213L | site-directed mutagenesis, analysis of substrate and cofactor binding compared to wild-type enzyme | Mycobacterium tuberculosis |
1.1.1.25 | D105N | site-directed mutagenesis, analysis of substrate and cofactor binding compared to wild-type enzyme | Mycobacterium tuberculosis |
1.1.1.25 | K69A | site-directed mutagenesis, analysis of substrate and cofactor binding compared to wild-type enzyme | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.25 | additional information | simulations of shikimate dehydrogenase from Mycobacterium tuberculosis in complex with 3-dehydroshikimate and NADPH for MtbSDH inhibition strategy, overview. Rational design of hybrid MtbSDH inhibitors able to bind in both the substrate (DHS) and cofactor (NADPH) pockets | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.25 | shikimate + NADP+ | Mycobacterium tuberculosis | - |
3-dehydroshikimate + NADPH + H+ | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.25 | Mycobacterium tuberculosis | A0A045GU47 | - |
- |
1.1.1.25 | no activity in Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.25 | shikimate + NADP+ | - |
Mycobacterium tuberculosis | 3-dehydroshikimate + NADPH + H+ | - |
r |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.1.1.25 | More | the overall structure of SDH comprises two alpha/beta domains linked centrally by two alpha-helices. A deep groove between these two domains contains the active site for the binding of substrate and cofactor | Mycobacterium tuberculosis |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.25 | AroE | - |
Mycobacterium tuberculosis |
1.1.1.25 | MtbSDH | - |
Mycobacterium tuberculosis |
1.1.1.25 | SDH | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.25 | NADP+ | - |
Mycobacterium tuberculosis | |
1.1.1.25 | NADPH | enzyme MtbSDH utilizes NADPH in the proS form, binding structure, overview | Mycobacterium tuberculosis |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.1.1.25 | metabolism | the enzyme is active in the shikimic acid pathway, which is present in bacteria, fungi, plants and in certain apicomplexan parasites but is absent from humans, pathway overview | Mycobacterium tuberculosis |
1.1.1.25 | additional information | molecular docking calculations and molecular dynamics (MD) simulations for enzyme-substrate interaction and binding structure analysis, model of DHS/NADPH/MtbSDH ternary complex, wild-type and mutant enzymes, detailed overview. Lys69 plays a dual role, in positioning NADPH and in catalysis. Asp105 plays a crucial role in positioning both the epsilon-amino group of Lys69 and nicotinamide ring of NADPH for MtbSDH catalysis but makes no direct contribution to DHS binding. Ala213 is the selection key for NADPH binding with the nicotinamide ring in the proS, rather than proR, conformation in the MtbSDH complex. Residues Ser18, Thr65, Lys69, Gln243, and Gln247 forming hydrogen bonds to 3-dehydroshikimate (DHS) | Mycobacterium tuberculosis |
1.1.1.25 | physiological function | shikimate dehydrogenase (SDH) from Mycobacterium tuberculosis (MtbSDH), encoded by the aroE gene, is essential for viability of Mycobacterium tuberculosis | Mycobacterium tuberculosis |